BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36419163)

  • 1. COVID-19 was not associated or trigger disease activity in spondylarthritis patients: ReumaCoV-Brasil cross-sectional data.
    Marques CDL; Ribeiro SLE; Albuquerque CP; de Sousa Studart SA; Ranzolin A; de Andrade NPB; Dantas AT; Mota GD; Resende GG; Marinho AO; Angelieri D; Andrade D; Ribeiro FM; Omura F; Silva NA; Rocha Junior L; Brito DE; Fernandino DC; Yazbek MA; Souza MPG; Ximenes AC; Martins ASS; Castro GRW; Oliveira LC; Freitas ABSB; Kakehasi AM; Gomides APM; Reis Neto ET; Pileggi GS; Ferreira GA; Mota LMH; Xavier RM; de Medeiros Pinheiro M;
    Adv Rheumatol; 2022 Nov; 62(1):45. PubMed ID: 36419163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-B27 did not protect against COVID-19 in patients with axial spondyloarthritis - data from the ReumaCov-Brasil Registry.
    Mota GD; Marques CL; Ribeiro SL; Albuquerque C; Castro G; Fernandino D; Omura F; Ranzolin A; Resende G; Silva N; Souza M; Studart S; Xavier R; Yazbek M; Pinheiro MM
    Adv Rheumatol; 2023 Nov; 63(1):56. PubMed ID: 38031143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interplay between COVID-19 and Secukinumab treatment in Spondylarthritis patients during the omicron surge: a retrospective cohort study.
    Wu T; Li Y; Huang D; Wu Y; Liang X; Cheng L; Liao Z; Xu F; Chen Y; Zhao J; Xia Z; Tan C; Liu Y; Herrmann M
    Autoimmunity; 2024 Dec; 57(1):2281242. PubMed ID: 38093504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High levels of immunosuppression are related to unfavourable outcomes in hospitalised patients with rheumatic diseases and COVID-19: first results of ReumaCoV Brasil registry.
    Marques CDL; Kakehasi AM; Pinheiro MM; Mota LMH; Albuquerque CP; Silva CR; Santos GPJ; Reis-Neto ET; Matos P; Devide G; Dantas A; Giorgi RD; Marinho AO; Valadares LDA; Melo AKG; Ribeiro FM; Ferreira GA; Santos FPS; Ribeiro SLE; Andrade NPB; Yazbek MA; Souza VA; Paiva ES; Azevedo VF; Freitas ABSB; Provenza JR; Toledo RA; Fontenelle S; Carneiro S; Xavier R; Pileggi GCS; Reis APMG
    RMD Open; 2021 Jan; 7(1):. PubMed ID: 33510041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Axial spondyloarthritis may protect against poor outcomes in COVID-19: propensity score matched analysis of 9766 patients from a nationwide multi-centric research network.
    Raiker R; Pakhchanian H; Kavadichanda C; Gupta L; Kardeş S; Ahmed S
    Clin Rheumatol; 2022 Mar; 41(3):721-730. PubMed ID: 34837569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do patients with rheumatoid arthritis show a different course of COVID-19 compared to patients with spondyloarthritis?
    Hasseli R; Pfeil A; Hoyer BF; Krause A; Lorenz HM; Richter JG; Schmeiser T; Voll RE; Schulze-Koops H; Specker C; Müller-Ladner U
    Clin Exp Rheumatol; 2021; 39(3):639-647. PubMed ID: 33822706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post COVID-19 hospitalizations in patients with chronic inflammatory diseases - A nationwide cohort study.
    Nørgård BM; Zegers FD; Nielsen J; Kjeldsen J
    J Autoimmun; 2021 Dec; 125():102739. PubMed ID: 34757259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 prognosis in systemic lupus erythematosus compared with rheumatoid arthritis and spondyloarthritis: results from the CONTROL-19 Study by the Italian Society for Rheumatology.
    Scirocco C; Ferrigno S; Andreoli L; Fredi M; Lomater C; Moroni L; Mosca M; Raffeiner B; Carrara G; Landolfi G; Rozza D; Zanetti A; Scirè CA; Sebastiani GD
    Lupus Sci Med; 2023 Oct; 10(2):. PubMed ID: 37848262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Brazilian Cohort of Patients With Immuno-Mediated Chronic Inflammatory Diseases Infected by SARS-CoV-2 (ReumaCoV-Brasil Registry): Protocol for a Prospective, Observational Study.
    Marques C; Kakehasi AM; Gomides APM; Paiva EDS; Dos Reis Neto ET; Pileggi GCS; Provenza JR; Mota L; Xavier RM; Ferreira GA; Pinheiro MM
    JMIR Res Protoc; 2020 Dec; 9(12):e24357. PubMed ID: 33156812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Respiratory tract infections and risk factors for infection in a cohort of 330 patients with axial spondyloarthritis or psoriatic arthritis.
    Frede N; Rieger E; Lorenzetti R; Nieters A; Venhoff AC; Hentze C; von Deimling M; Bartholomä N; Thiel J; Voll RE; Venhoff N
    Front Immunol; 2022; 13():1040725. PubMed ID: 36389682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depressive symptoms are associated with fatigue, poorer functional status and less engagement in sports in axSpA and PsA: an analysis from the RABBIT-SpA cohort.
    Reich A; Weiß A; Lindner L; Baraliakos X; Poddubnyy D; Zinke S; Stille C; Strangfeld A; Regierer AC
    Arthritis Res Ther; 2023 Aug; 25(1):136. PubMed ID: 37533077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with poor outcomes in SLE patients with COVID-19: Data from
    Carvalho JS; Dos Reis Neto ET; Kakehasi AM; Ribeiro SL; Studart SA; Martins FP; Cavalheiro do Espírito Santo R; Ranzolin A; Fernandino DC; Dinis VG; Sato EI; Resende GG; Marinho A; Mariz HA; Sacilotto NC; Ribeiro FM; Shinjo SK; Dias LH; Yazbek MA; Omura F; Rached TH; Gomides APM; Marques CD; Pillegi GC; Mota LM; Pinheiro MM; Monticielo OA; Xavier RM; Ferreira GA;
    Lupus; 2023 Jan; 32(1):42-53. PubMed ID: 36300790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comorbidities Associated with Psoriatic Arthritis Compared with Non-psoriatic Spondyloarthritis: A Cross-sectional Study.
    Haque N; Lories RJ; de Vlam K
    J Rheumatol; 2016 Feb; 43(2):376-82. PubMed ID: 26669922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of the COVID-19 pandemic on treat-to-target strategies and physical consultations in >7000 patients with inflammatory arthritis.
    Glintborg B; Jensen DV; Terslev L; Pfeiffer Jensen M; Hendricks O; Østergaard M; Engel S; Horskjær Rasmussen S; Adelsten T; Colic A; Danebod K; Kildemand M; Loft AG; Munk HL; Pedersen JK; Østgård RD; Møller Sørensen C; Krogh NS; Nørgaard Agerbo J; Ziegler C; Hetland ML
    Rheumatology (Oxford); 2021 Oct; 60(SI):SI3-SI12. PubMed ID: 34146099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidisciplinary Team Led by Joint Surgeons to Rapidly Identify Spondyloarthritis.
    Wang D; Yu X; Shi X; Ma H; Zhang H; Liu B; Fang L; Lv J; Zhang K; Bai X; Ren B
    Altern Ther Health Med; 2023 Jan; 29(1):231-237. PubMed ID: 36150014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of enthesitis on 1505 Brazilian patients with spondyloarthritis.
    Carneiro S; Bortoluzzo A; Gonçalves C; Silva JA; Ximenes AC; Bértolo M; Ribeiro SL; Keiserman M; Skare T; Menin R; Azevedo V; Vieira W; Albuquerque E; Bianchi W; Bonfiglioli R; Campanholo C; Carvalho HM; Costa Id; Duarte A; Kohem C; Leite N; Lima SA; Meirelles ES; Pereira IA; Pinheiro MM; Polito E; Resende GG; Rocha FA; Santiago MB; Sauma Mde F; Valim V; Sampaio-Barros PD
    J Rheumatol; 2013 Oct; 40(10):1719-25. PubMed ID: 23858049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of baseline modified Rheumatic Disease Comorbidity Index (mRDCI) on drug survival and effectiveness of biological treatment in patients affected with Rheumatoid arthritis, Spondyloarthritis and Psoriatic arthritis in real-world settings.
    Iannone F; Salaffi F; Fornaro M; Di Carlo M; Gentileschi S; Cantarini L; Lopalco G
    Eur J Clin Invest; 2018 Nov; 48(11):e13013. PubMed ID: 30079593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors Associated With Mortality in Patients With Immune-Mediated Rheumatic Diseases and COVID-19 From Latin America: Data From Argentina, Mexico, and Brazil.
    Isnardi CA; Alpizar-Rodriguez D; Calderaro DC; Marques CDL; Pons-Estel GJ; Xavier RM; Saurit V; Pisoni CN; Tissera YS; D'Angelo Exeni ME; Alba P; Pereira D; Gobbi CA; Gamba MJ; Alfaro MA; Virasoro BM; Colunga-Pedraza IJ; Irazoque-Palazuelos F; Reyes-Cordero G; Rodriguez-Reyna TS; Veloz-Aranda JA; Skinner-Taylor CM; Juárez-Mora IM; Silveira LH; Pacheco Tena CF; Xibille-Friedmann DX; Ferreira GA; Kakehasi AM; Pinheiro MM; Gomides APM; Pileggi GCS; da Mota LMH; Dos Reis-Neto ET; Ribeiro SLE; de Azevedo Valadares LD; Martínez-Martínez MU
    J Clin Rheumatol; 2024 Jan; 30(1):e9-e17. PubMed ID: 37936271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with long-term retention of treatment with golimumab in rheumatoid arthritis, axial spondyloarthritis, and psoriatic arthritis: an analysis of the Spanish BIOBADASER registry.
    Pombo-Suarez M; Sanchez-Piedra C; Garcia-Magallón B; Pérez-Gómez A; Manrique-Arija S; Martín-Doménech R; Colazo M; Campos C; Campos J; Del Pino-Montes J; Arteaga MJ; Cea-Calvo L; Díaz-González F; Gómez-Reino JJ
    Clin Rheumatol; 2021 Oct; 40(10):3979-3988. PubMed ID: 33907904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and Prevalence of Major Adverse Cardiovascular Events in Rheumatoid Arthritis, Psoriatic Arthritis, and Axial Spondyloarthritis.
    Lauper K; Courvoisier DS; Chevallier P; Finckh A; Gabay C
    Arthritis Care Res (Hoboken); 2018 Dec; 70(12):1756-1763. PubMed ID: 29609199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.